Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Phosphoproteomic Characterization and Kinase Signature Predict Response to Venetoclax Plus 3+7 Chemotherapy in Acute Myeloid Leukemia.
Authors: Jin, Jie1,2,3,4,5 (AUTHOR), Hou, Shangyu6 (AUTHOR), Yao, Yiyi1,2 (AUTHOR), Liu, Miaomiao6 (AUTHOR), Mao, Liping1,2,3 (AUTHOR), Yang, Min1,2,3 (AUTHOR), Tong, Hongyan1,2,3,4 (AUTHOR), Zeng, Tao7 (AUTHOR), Huang, Jinyan7 (AUTHOR), Zhu, Yinghui6,8 (AUTHOR) zhuyinghui@tongji.edu.cn, Wang, Huafeng1,2,3,4 (AUTHOR) 1509036@zju.edu.cn
Source: Advanced Science. 3/20/2024, Vol. 11 Issue 11, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202305885